Global Atherectomy Devices Market to Reach USD 2.21 Billion by 2033 Driven by PAD Prevalence and Technological Advancements

According to Renub Research Latest Report atherectomy devices market is projected to expand from USD 1.05 billion in 2024 to USD 2.21 billion by 2033, registering a CAGR of 8.63% from 2025 to 2033. Key factors driving this growth include the rising prevalence of peripheral artery disease (PAD), rapid technological advancements, an aging population, increased adoption of minimally invasive surgeries, and the development of healthcare infrastructure supported by reimbursement policies in emerging economies.

Understanding Atherectomy Devices

Atherectomy devices are medical instruments used to remove plaque from arteries in patients suffering from coronary artery disease (CAD) or peripheral arterial disease (PAD). These devices work by manually cutting, grinding, or vaporizing arterial plaque, restoring blood flow and alleviating symptoms such as chest pain, leg pain, or fatigue.

The minimally invasive nature of atherectomy procedures offers faster recovery times and fewer complications compared to traditional surgery. Atherectomy devices come in several types, including rotational, directional, laser, and orbital systems, each designed for specific therapeutic approaches. These tools are crucial for patients unsuitable for stent placement or balloon angioplasty, providing effective alternatives for arterial plaque management.

👉 Want to explore detailed market trends, segment insights, and forecasts? 🔗 Request Free Sample Report

Key Market Drivers

1. Rising Peripheral Artery Disease (PAD) Prevalence

The market is driven by the increasing number of PAD patients worldwide, largely linked to diabetes, obesity, and aging populations. In the United States alone, 8–12 million individuals suffer from PAD, with 6.5 million over the age of 40 diagnosed with the condition.

Atherectomy devices provide a minimally invasive solution to remove arterial plaque, improving blood flow and reducing PAD symptoms such as leg pain and fatigue. These devices enhance arterial patency, significantly improving patient outcomes in severe PAD cases.

2. Technological Advancements

Rapid technological innovations are boosting the adoption of atherectomy devices. Device improvements have enhanced efficiency, accuracy, and safety, allowing for precise plaque removal while minimizing vessel damage.

For instance, advancements in rotational, orbital, and laser atherectomy systems, combined with real-time imaging techniques like optical coherence tomography (OCT) and intravascular ultrasonography (IVUS), enable clinicians to navigate arterial blockages with precision. Ergonomic designs and user-friendly devices have further improved procedural speed and patient outcomes.

A notable development in August 2022 was AngioDynamics, Inc. receiving 510(k) clearance for the Auryon Atherectomy System, expanding indications to include arterial thrombectomy, illustrating the market’s focus on innovation.

3. Expansion in Emerging Markets

Emerging markets, including Asia-Pacific, the Middle East, and Latin America, are becoming major growth drivers for atherectomy devices. Rising awareness of cardiovascular disorders, improving healthcare infrastructure, increased disposable income, and favorable government initiatives are accelerating device adoption.

Growing knowledge about minimally invasive therapies and improved access to cutting-edge treatments are encouraging patients in these regions to opt for atherectomy procedures, providing an attractive growth opportunity for market players.

4. Aging Population

The aging population is a critical factor fueling demand for atherectomy devices. Older adults are more susceptible to atherosclerosis and PAD, increasing the need for effective, minimally invasive treatments. With advances in healthcare extending life expectancy, the global demand for atherectomy devices is expected to rise steadily.

Challenges in the Atherectomy Devices Market

1. Lack of Skilled Operators

A major challenge is the shortage of trained clinicians capable of performing atherectomy procedures safely. The complexity of using rotational, laser, or orbital systems requires specialized training. Limited access to trained personnel can hinder device adoption, particularly in developing regions. Training programs are often time-consuming and expensive, posing a barrier to market expansion.

2. High Costs

The high cost of atherectomy devices and procedures is another significant constraint. Sophisticated technology increases production and procurement expenses, which may deter healthcare providers in low- and middle-income regions. Patients may also find the total procedure cost, including hospital fees, prohibitive, especially where reimbursement policies are limited. Despite their effectiveness, high costs can limit access and adoption.

Regional Market Insights

North America

North America dominates the atherectomy devices market due to a well-established healthcare system and strong demand for minimally invasive treatments. In the US, the geriatric population—projected at 55.8 million in 2023 (16.8% of the total population)—drives demand for PAD treatments.

Chronic conditions such as atherosclerosis, diabetes, obesity, and high cholesterol increase the need for atherectomy procedures. Around 25 million adults in the US have high cholesterol, according to CDC data (May 2024), further emphasizing the importance of these devices in cardiovascular care.

Europe

Europe is the second-largest market, with Germany leading due to its robust healthcare infrastructure and the rising prevalence of cardiovascular diseases. Favorable reimbursement policies and technological developments in atherectomy devices also support growth. Risk factors such as diabetes, obesity, and high cholesterol in the elderly population further drive demand.

Asia-Pacific

The Asia-Pacific market is growing rapidly due to increased awareness of cardiovascular diseases, improving healthcare systems, and higher disposable incomes. India and China, in particular, are witnessing strong demand for minimally invasive procedures, aided by government initiatives and technological advancements.

Latin America and Middle East & Africa

Markets in Latin America and the Middle East are expanding due to rising healthcare spending, demand for cutting-edge medical technology, and improved access to modern treatments. In Saudi Arabia, for instance, growing awareness of PAD and cardiovascular disorders, coupled with investments in advanced medical devices, is driving atherectomy adoption.

👉 For deeper analysis, detailed segment data, and company insights: 🔗 Request Customization Report

Atherectomy Devices Market Segmentation

By Product Type:

Directional

Rotational

Orbital

Laser

By Application:

Cardiovascular

Neurovascular

Peripheral Vascular

By End-User:

Hospitals

Ambulatory Care Services

Medical Research Institutes

By Region:

North America: US, Canada

Europe: France, Germany, Italy, Spain, UK, Belgium, Netherlands, Turkey

Asia-Pacific: China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand

Latin America: Brazil, Mexico, Argentina

Middle East & Africa: Saudi Arabia, UAE, South Africa

Competitive Landscape

Key companies are driving innovation, expanding product portfolios, and developing advanced atherectomy devices:

Boston Scientific Corporation, Inc.

Abbott Laboratories

Medtronic plc

Cardinal Health

Terumo Corporation

Integer Holdings Corporation

Becton, Dickinson and Company

AngioDynamics Inc.

These companies focus on device efficacy, safety, and ergonomic design, targeting both established and emerging markets to meet growing demand for minimally invasive procedures.

Future Outlook

The global atherectomy devices market is poised for robust growth through 2033, driven by rising PAD cases, technological innovation, and the adoption of minimally invasive surgical techniques. Expansion into emerging markets, combined with increasing awareness of cardiovascular health and improved healthcare infrastructure, presents strong growth opportunities.

Challenges such as high costs and lack of skilled operators may slow adoption in certain regions. However, continuous innovation in device technology, ergonomic design improvements, and government healthcare initiatives are expected to mitigate these challenges and support long-term market growth.

By 2033, the global market is expected to reach USD 2.21 billion, reflecting a strong demand for effective, minimally invasive solutions to manage cardiovascular and peripheral vascular diseases worldwide.

Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.